Finance

Lists
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
US$ ४.३३
-१.८१%
(-०.०८०) 1D
US$ ४.२५
-१.८५% (-०.०८०)
After hours
Closed: अक्टोबर १५, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
US$ ४.४०
High
US$ ४.६२
Low
US$ ४.२३
Mkt. cap
८.३७ करोड
Avg. vol.
१२.२८ लाख
Volume
१०.९० लाख
52-wk high
US$ २०.५६
52-wk low
US$ ४.२३
EPS
-US$ ६.१७
Beta
२.६३
Shares outstanding
१.९३ करोड
No. of employees
३६
Open
US$ ४.४०
High
US$ ४.६२
Low
US$ ४.२३
Mkt. cap
८.३७ करोड
Avg. vol.
१२.२८ लाख
Volume
१०.९० लाख
52-wk high
US$ २०.५६
52-wk low
US$ ४.२३
EPS
-US$ ६.१७
Beta
२.६३
Shares outstanding
१.९३ करोड
No. of employees
३६
News stories
From web sources and news partners
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees३६
Founded२००९ जनवरी १
Headquarters-
Sector-
Websitecorbuspharma.com
Analyst ratings
Based on 7 analysts giving stock ratings to CRBP in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current US$ ४.३३
US$ ४८.०० (+१,००८.५५%)
Average
US$ ३६.६७ (+७४६.८८%)
Lowest
US$ ३०.०० (+५९२.८४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
US$ ३०.००
+५९२.८%
09/15/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
US$ ३५.००
+७०८.३%
09/15/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
09/14/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
US$ ३८.००
+७७७.६%
09/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
US$ ३३.००
+६६२.१%
09/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
US$ ३६.००
+७३१.४%
08/12/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
US$ ४८.००
+१,००८.५%
08/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
US$ ४८.००
+१,००८.५%
08/07/2026
Paul Jeng
Guggenheim
Buy
Maintained
US$ ४५.००
+९३९.३%
06/02/2026
Unknown Analyst
Wedbush
Buy
Reiterated
US$ ३८.००
+७७७.६%
05/13/2026
Maury Raycroft
Jefferies
Buy
Maintained
US$ ३३.००
+६६२.१%
05/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
US$ २८.००
+५४६.७%
04/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
२.०९ करोड
१.८४ करोड
१.९८ करोड
३.१२ करोड
Cost of revenue
२.०९ करोड
१.८४ करोड
१.९८ करोड
३.१२ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३५.५७ लाख
३५.६० लाख
४४.८५ लाख
५०.१५ लाख
Operating expense
३५.५७ लाख
३५.६० लाख
४४.८५ लाख
५०.१५ लाख
Total operating expenses
२.४४ करोड
२.२० करोड
२.४३ करोड
३.६२ करोड
Operating income
-२.४४ करोड
-२.२० करोड
-२.४३ करोड
-३.६२ करोड
Other non operating income
-५०.०० हजार
-१०.९९ लाख
-६७.०० हजार
-११.०० हजार
EBT including unusual items
-२.३३ करोड
-२.०६ करोड
-२.३० करोड
-३.५० करोड
EBT excluding unusual items
-२.३३ करोड
-२.१७ करोड
-२.३० करोड
-३.५० करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.३३ करोड
-२.०६ करोड
-२.३० करोड
-३.५० करोड
Net profit margin
-
-
-
-
Earnings per share
-१.९०
-१.२५
-१.२३
-१.८१
Interest and investment income
११.२५ लाख
१४.१० लाख
१४.०२ लाख
११.६४ लाख
Interest expense
-
-
-
-
Net interest expenses
११.२५ लाख
१४.१० लाख
१४.०२ लाख
११.६४ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.४४ करोड
-२.१९ करोड
-२.४३ करोड
-३.६१ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू